Presented By:
Kelly Doyle
Medical Director: Special Chemistry and Endocrinology - Assistant Professor, University of Utah School of Medicine
Randie R. Little
Director, Diabetes Diagnostic Laboratory (DDL) - Network Coordinator, NGSP
David B. Sacks
Senior Investigator - Chief, Clinical Chemistry Service - NIH
Speaker Biography:
Dr. Kelly Doyle is a fellow in the National Academy of Clinical Biochemistry and is a board certified clinical chemist. His interests involve the clinical application and implementation of mass spectrometry, emerging biomarkers, toxicology, endocrinology, and laboratory best practice. He has a special interest in training clinical chemistry fellows and teaching principles of laboratory medicine to pathology residents and medical students.
Randie Little, PhD is a Research Professor in the Departments of Pathology & Anatomical Sciences and Child Health at the University of Missouri and is Director of the Diabetes Diagnostic Laboratory (DDL). Dr. Little is the coordinator of the NGSP (National Glycohemoglobin Standardization Program) network, a member of the NGSP Steering Committee and also coordinates NIDDK- sponosored C-peptide Standardization activities. The DDL, is the primary site of the NGSP, an international program for standardization of HbA1c which is the most important test used to assess glycemic control in patients with diabetes. The NGSP maintains a worldwide laboratory network with reference method results that are based on landmark clinical trial data. The program certifies manufacturer methods for HbA1c and also certifies and monitors laboratories doing large studies and clinical trials where measurement of HbA1c is a key variable. The NGSP network assigns values to the accuracy based College of American Pathologists (CAP) HbA1c survey. Related research includes examination of stability of HbA1c and interferences (e.g. from Hb variants) with different assay methods. Standardization of c‐peptide is also in progress at the DDL; the DDL has established an LS/MS reference method for c‐peptide as well as a complete traceability chain for C-peptide.
David Sacks is Senior Investigator and Chief of Clinical Chemistry Service at the National Institutes of Health, Adjunct Professor of Medicine at Georgetown University, Clinical Professor of Pathology at George Washington University and Honorary Professor of Clinical Laboratory Sciences at the University of Cape Town. He received his medical training at the University of Cape Town. He completed residencies in Internal Medicine at Georgetown University affiliated hospitals in Washington, D.C. and in Clinical Pathology at Washington University, St. Louis. After fellowship training in Clinical Chemistry at Washington University, he spent 21 years in the Department of Pathology at Harvard Medical School.
Webinar:
Analytical Limitations of HbA1c: Factors to consider when choosing an HbA1c Methodology
Webinar Abstract:
With many methods available for HbA1c testing, how do you choose a method that’s best for your laboratory? The incidence and prevalence of diabetes mellitus is on the rise, and so is the use of HbA1c in the clinical laboratory. HbA1c is routinely used as the gold standard test to monitor, diagnose, and manage diabetic patients. However, there are several limitations to HbA1c as an assay in diabetes screening, including methodology, analytical interference, and biological interference. Different methodologies exist today to measure HbA1c such as immunoassay, enzymatic, HPLC and capillary electrophoresis. While many commercial methodologies are standardized, what are the limitations to each of these methods? What do you need to consider when choosing an HbA1c method for your laboratory?
Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots ([ Ссылка ])
2. Watch the webinar on YouTube or on the LabRoots Website ([ Ссылка ])
3. Click Here to get your PACE credits (Expiration date – DEC 04, 2022): ([ Ссылка ])
LabRoots on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Pinterest: [ Ссылка ]
SnapChat: labroots_inc
